We translate measures of efficacy into measures of effectiveness and cost-effectiveness by embracing or creating state-of-the-art epidemiological and economic models to evaluate the real-world impact of ill-health and the real-world benefits of interventions, covering the scope of healthcare delivery from screening to treatment to rehabilitation.
We have a deep, practical understanding of healthcare needs and health systems. Our focus is firmly on how we can generate and use new knowledge to shape practice and policy.
Who we are
Our staff are internationally recognised in their fields. Our leadership team holds expertise in health economics, epidemiological modelling, productivity and efficiency measurement, while our wider team of collaborators and students comprises clinicians, allied health professionals, epidemiologists, evidence synthesis experts and clinical triallists.
Leader: Professor Danny Liew
Our stream leaders manage their own specialised research portfolios, but often work together when their unique expertise is called for.
- Associate Professor Zanfina Ademi – Cardiovascular Disease and Diabetes; Epilepsy; and Healthy Lifestyle in Preconception, Pregnancy and Postpartum
- Associate Professor Ilana Ackerman – Musculoskeletal Diseases
- Associate Professor Emily Callander – Women, Maternal and Child Health
- Dr Ella Zomer – Diabetes and Obesity
- Professor Danny Liew – Chronic Diseases; Drugs and Devices
Academic Staff: Prof Christopher Reid, Prof Dianna Magliano, Prof Patrick Kwan, Assoc Prof Daryl Jones, Assoc Prof Dion Stub, Dr Anthony Pease, Dr Julia Gilmartin-Thomas, Dr Melanie Lloyd, Dr Stella Talic, Dr Sze-Ee Soh, Dr Zhibin Chen, Claudia Bull, Danielle Berkovic, Peter Markey, Yanan Hu
Research Assistants: Dr Mariana Petrova, Catherine Brown, Eri Asakura, Feby Savira, Megumi Lim,
Adjunct staff: Dr Alice Owen, Dr Ken Chin, Dr Richard Ofori-Asenso, Dr Tom Hird
Graduate Students: Dina Abushanab, Yeji Baek, Dr Cate Bailey, Dr Haryo Bismantara, Bonnie Eklom, Dr Emma Foster, Md Nassif Hossain, Shae Karger, Hansoo Kim, Peter Lee, Clara Marquina, Emily Olive, Catriona Parker, Aimy Tran, Dr Ai Li Yeo
Our core strengths
- Economic evaluation alongside clinical trials and clinical registries.
- Epidemiological and economic modelling.
- Economic evaluation of health systems.
- Health technology assessment (HTA) and health program evaluation.
- Application of patient-reported outcome measures (PROMs) to inform value-based healthcare.
- Psychometric validation of new patient-reported outcome measures.
- Productivity measurement.
- Equity analysis.
- Data linkage and analysis of administrative data.
Who we work with
We enjoy a rich network of global collaborators, including the Global Burden of Disease Collaborator Network and academic institutions across the world. We consult to the Victorian, Queensland and Commonwealth governments, and have advised the Australian Orthopaedic Association National Joint Replacement Registry, the Australian Spine Registry, Hong Kong Hospital Authority and the United Arab Emirates, Indonesian, Switzerland and New Zealand Ministries of Health. We also undertake consultancy work for the private healthcare industry.